Literature DB >> 10443159

Fatal peyote ingestion associated with Mallory-Weiss lacerations.

K B Nolte, R E Zumwalt.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10443159      PMCID: PMC1305682     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  4 in total

1.  Botulism from peyote.

Authors:  H Hashimoto; V J Clyde; K L Parko
Journal:  N Engl J Med       Date:  1998-07-16       Impact factor: 91.245

Review 2.  Peyote constituents: chemistry, biogenesis, and biological effects.

Authors:  G J Kapadia; M B Fayez
Journal:  J Pharm Sci       Date:  1970-12       Impact factor: 3.534

3.  Mallory-Weiss syndrome: an unusual complication of ipecac-induced emesis.

Authors:  D Tandberg; E J Liechty; D Fishbein
Journal:  Ann Emerg Med       Date:  1981-10       Impact factor: 5.721

4.  A mescaline associated fatality.

Authors:  P C Reynolds; E J Jindrich
Journal:  J Anal Toxicol       Date:  1985 Jul-Aug       Impact factor: 3.367

  4 in total
  4 in total

Review 1.  Alternative drugs of abuse.

Authors:  M E Sutter; J Chenoweth; T E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

Review 2.  Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.

Authors:  Ricardo Jorge Dinis-Oliveira; Carolina Lança Pereira; Diana Dias da Silva
Journal:  Curr Mol Pharmacol       Date:  2019       Impact factor: 3.339

Review 3.  Herbal Highs: Review on Psychoactive Effects and Neuropharmacology.

Authors:  Silvia Graziano; Laura Orsolini; Maria Concetta Rotolo; Roberta Tittarelli; Fabrizio Schifano; Simona Pichini
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

4.  The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects.

Authors:  Malin Vedøy Uthaug; Alan K Davis; Trevor Forrest Haas; Dawn Davis; Sean B Dolan; Rafael Lancelotta; Christopher Timmermann; Johannes G Ramaekers
Journal:  J Psychopharmacol       Date:  2021-05-05       Impact factor: 4.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.